BSE filing, NSE: INFRONICS. Summary written from the filing by ALFA Finder's alert engine.
Infronics Systems Ltd: key numbers
- Share price
- ₹17.64
- Market cap
- ₹13.98 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.75 Cr
- P/E (TTM)
- -19.0×Sector 23.0×
- Promoter holding
- 53.55%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Infronics Systems Ltd
All →Infronics Systems Board Meeting Date
Infronics Systems Limited scheduled a board meeting for October 29, 2026, to consider and approve the standalone unaudited financial results for the quarter ended September 2026.
Infronics Systems Annual General Meeting
Infronics Systems Ltd announced the results of its adjourned 26th Annual General Meeting. Shareholders approved the annual financial statements and re-appointment of a director.
Infronics Systems Annual General Meeting
Infronics Systems Ltd adjourned its 26th Annual General Meeting due to technical issues with the meeting facility. It is rescheduled for October 07, 2026.
Infronics Systems Other Announcement
The company has dispatched letters to shareholders providing the web-link to access the 26th Annual Report and notice for the upcoming Annual General Meeting.
Infronics Systems Annual Report
Infronics Systems Limited has submitted its 26th Annual Report for the financial year 2025-2026 to the stock exchange.
Infronics Systems Annual General Meeting
Infronics Systems Limited has scheduled its 26th Annual General Meeting for September 30, 2026, to be held via video conferencing.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.